FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and medicine. Use of 4-amino-3-phenylbutanoic acid hydrochloride of the following structural formula (I) as an agent having the property of preventing the death of GABAergic neurons in conditions of acute perinatal hypoxia is proposed. Low toxicity of the compound provides its long-term use for pharmacological correction of the consequences of CNS damage in children with perinatal hypoxia. structural formula (I).
EFFECT: technical result consists in the expressed property to prevent damage and death of GABAergic neurons in conditions of acute perinatal hypoxia both on the 20th and on the 40th day of postnatal development.
1 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR PRESERVING POPULATION OF GABA-ERGIC NEURONS AFTER ACUTE PERINATAL HYPOXIA | 2017 |
|
RU2672884C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS | 2019 |
|
RU2717107C1 |
AGENT POSSESSING CARDIOPROTECTIVE, ANTIPLATELET, ANTICOAGULANT AND MEMBRANE-PROTECTIVE PROPERTIES UNDER STRESS STIMULATION | 2013 |
|
RU2531080C1 |
METHOD OF THE TREATMENT OF THE BRAIN IN ACUTE HYPOXIA WITH HYPERCAPNIA | 2022 |
|
RU2803387C1 |
AGENT POSSESSIVE CARDIOPROTECTIVE ACTION UNDER STRESS STIMULATION | 2013 |
|
RU2531082C1 |
AGENT POSSESSING ENDOTHELIUM PROTECTIVE EFFECT IN CONDITIONS OF EXPERIMENTAL DIABETES MELLITUS AND CEREBRAL BLOOD CIRCULATION DISORDER | 2015 |
|
RU2601622C1 |
MEDICATION PRODUCING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTIAMNESTIC ACTION IN ACUTE PERIODE OF CRANIOCEREBRAL TRAUMA | 2009 |
|
RU2424802C2 |
Authors
Dates
2018-11-21—Published
2017-10-25—Filed